Ovarian Cancer

>

Latest News

Estrogen Therapy May Impact Ovarian/Endometrial Cancer Incidence in Postmenopausal Women After Hysterectomy
Estrogen Therapy May Impact Ovarian/Endometrial Cancer Incidence in Postmenopausal Women After Hysterectomy

May 24th 2024

Postmenopausal women who had undergone hysterectomy and received treatment with conjugated equine estrogen alone had an increased incidence of ovarian cancer and mortality rates.

Olaparib Plus Cediranib May Not Provide Survival Benefit in Platinum-Resistant or Refractory Ovarian Cancer
Olaparib Plus Cediranib May Not Provide Survival Benefit in Platinum-Resistant or Refractory Ovarian Cancer

March 21st 2024

Mirvetuximab Soravtansine Bests Chemo in HRQOL for FRα+ Ovarian Cancer
Mirvetuximab Soravtansine Bests Chemo in HRQOL for FRα+ Ovarian Cancer

March 20th 2024

Frontline Maintenance Niraparib May Not Worsen HRQOL in Advanced Ovarian Cancer
Frontline Maintenance Niraparib May Not Worsen HRQOL in Advanced Ovarian Cancer

March 17th 2024

Avutometinib Receives Orphan Drug Designation for Recurrent Low-Grade Serous Ovarian Cancer
Avutometinib Receives Orphan Drug Designation for Recurrent Low-Grade Serous Ovarian Cancer

March 16th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.